ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 201863 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 201863; 2) Community: the network communities that were significantly associated with the response to NSC 201863; 3) Molecule: the relationships between components within communities and NSC 201863; 4) MDR: the compounds that were significantly associated with the NSC 201863.

NSC Compound Enrichment Correlation
NSC 269720 Androstan-17-one, 3-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (3.alpha.,5.alpha.)- 0.039607714093338 0.39699319
NSC 30915 Null 0.039607714093338 -0.1219979
NSC 328784 1-Piperazinecarboselenoic acid, 4-(2-pyridinyl)-, [1-(2-pyridinyl)ethylidene]hydrazide 0.039607714093338 -0.22298211
NSC 359239 Antibiotic X-14766A 0.039607714093338 -0.03586141
NSC 40618 Cyclohexanone, 2,6-dibenzylidene- (8CI) 0.039607714093338 -0.27997644
NSC 606497 Camptothecin Derivative 0.039607714093338 0.26972358
NSC 631371 N-(3,5-Dimethoxybenzyl)-4-methoxyaniline 0.039607714093338 -0.22003417
NSC 642947 Methanone, [3-(dibromomethyl)-6-chloroquinolin-2-yl] phenyl- 0.039607714093338 -0.20962872
NSC 645571 Null 0.039607714093338 0.085743431
NSC 649312 Null 0.039607714093338 -0.011713322
Total:46  Current:39    [First] [Prev] [Next] [Last]